ARDELYX, INC. (ARDX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $25.00K; Additional Paid in Capital, Common StockUSD $1.15B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-193.00K; Retained Earnings (Accumulated Deficit)USD $-1.00B.
- 2026-03-31: Common Stock, Value, IssuedUSD $25.00K; Additional Paid in Capital, Common StockUSD $1.13B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-124.00K; Retained Earnings (Accumulated Deficit)USD $-984.54M.
- 2025-12-31: Common Stock, Value, IssuedUSD $24.00K; Additional Paid in Capital, Common StockUSD $1.11B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $198.00K; Retained Earnings (Accumulated Deficit)USD $-946.94M.
- 2025-09-30: Common Stock, Value, IssuedUSD $24.00K; Additional Paid in Capital, Common StockUSD $1.10B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $124.00K; Retained Earnings (Accumulated Deficit)USD $-946.53M.
ARDELYX, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | Additional Paid in Capital USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.00K | $1.15B | $-193.00K | $-1.00B | $149.01M | 3 month · $15.32M 6 month · $29.47M | (m) | (m) |
| 2026-03-31 | $25.00K | $1.13B | $-124.00K | $-984.54M | $148.62M | 3 month · $14.16M | (m) | (m) |
| 2025-12-31 | $24.00K | $1.11B | $198.00K | $-946.94M | $166.95M | 12 month · $48.96M | (m) | (m) |
| 2025-09-30 | $24.00K | $1.10B | $124.00K | $-946.53M | $154.28M | 3 month · $12.74M 9 month · $36.52M | (m) | (m) |
| 2025-06-30 | $24.00K | $1.09B | $-38.00K | $-945.56M | $139.53M | 3 month · $11.69M 6 month · $23.77M | (m) | (m) |
| 2025-03-31 | $24.00K | $1.07B | $18.00K | $-926.48M | $145.68M | 3 month · $12.09M | (m) | (m) |
| 2024-12-31 | $24.00K | $1.06B | $57.00K | $-885.34M | $173.29M | 12 month · $37.38M | (m) | (m) |
| 2024-09-30 | $24.00K | $1.05B | $185.00K | $-889.99M | $158.30M | 3 month · $9.13M 9 month · $27.52M | (m) | (m) |
| 2024-06-30 | $23.00K | $1.04B | $-101.00K | $-889.18M | $146.99M | 3 month · $10.77M 6 month · $18.39M | (m) | (m) |
| 2024-03-31 | $23.00K | $1.02B | $-20.00K | $-872.72M | $150.89M | 3 month · $7.62M | $0.00 | (m) |
| 2023-12-31 | $23.00K | $1.01B | $224.00K | $-846.20M | $166.82M | 12 month · $13.53M | $0.00 | (m) |
| 2023-09-30 | $23.00K | $1.01B | $-201.00K | $-817.40M | $191.16M | 3 month · $3.49M 9 month · $9.60M | $0.00 | (m) |
| 2023-06-30 | $22.00K | $947.38M | $-210.00K | $-824.03M | $123.16M | 3 month · $3.20M 6 month · $6.11M | $0.00 | (m) |
| 2023-03-31 | $21.00K | $932.33M | $-20.00K | $-806.91M | $125.42M | 3 month · $2.91M | $0.00 | (m) |
| 2022-12-31 | $20.00K | $878.50M | $-54.00K | $-780.14M | $98.33M | 12 month · $10.75M | $0.00 | (m) |
| 2022-09-30 | $19.00K | $857.79M | $-114.00K | $-790.83M | $66.86M | 3 month · $1.85M 9 month · $8.82M | $0.00 | (m) |
| 2022-06-30 | $15.00K | $821.08M | $-109.00K | $-767.94M | $53.04M | 3 month · $3.25M 6 month · $6.98M | $0.00 | (m) |
| 2022-03-31 | $14.00K | $805.26M | $-88.00K | $-741.00M | $64.19M | 3 month · $3.72M | $0.00 | (m) |
| 2021-12-31 | $13.00K | $795.54M | $-6.00K | $-712.93M | $82.62M | 12 month · $12.04M | $0.00 | (m) |
| 2021-09-30 | $11.00K | $758.11M | $3.00K | $-676.70M | $81.43M | 3 month · $2.26M 9 month · $8.57M | $0.00 | (m) |
| 2021-06-30 | $10.00K | $750.66M | $4.00K | $-633.11M | $117.57M | 3 month · $3.22M 6 month · $6.31M | $0.00 | (m) |
| 2021-03-31 | $10.00K | $718.73M | $-7.00K | $-587.92M | $130.81M | 3 month · $3.09M | $0.00 | (m) |
| 2020-12-31 | $9.00K | $680.87M | $-4.00K | $-554.76M | $126.11M | 12 month · $10.58M | $0.00 | (m) |
| 2020-09-30 | $9.00K | $657.13M | $90.00K | $-525.89M | $131.34M | 3 month · $2.53M 9 month · $8.15M | (m) | (m) |
| 2020-06-30 | $9.00K | $653.80M | $317.00K | $-507.78M | $146.35M | 3 month · $2.67M 6 month · $5.62M | (m) | (m) |
| 2020-03-31 | $9.00K | $650.62M | $-44.00K | $-482.82M | $167.76M | 3 month · $2.95M | (m) | (m) |
| 2019-12-31 | $9.00K | $647.08M | $20.00K | $-460.45M | $186.66M | 12 month · $9.94M | (m) | (m) |
| 2019-09-30 | $6.00K | $489.81M | $4.00K | $-440.66M | $49.16M | 3 month · $3.88M 9 month · $7.72M | (m) | (m) |
| 2019-06-30 | $6.00K | $485.72M | $16.00K | $-417.12M | $68.62M | 3 month · $1.92M 6 month · $3.85M | (m) | (m) |
| 2019-03-31 | $6.00K | $483.48M | $12.00K | $-391.66M | $91.84M | 3 month · $1.92M | (m) | (m) |
| 2018-12-31 | $6.00K | $481.36M | $-38.00K | $-365.51M | $115.81M | 12 month · $9.23M | (m) | (m) |
| 2018-09-30 | $6.00K | $479.11M | $-17.00K | $-337.65M | $141.45M | 3 month · $1.95M 9 month · $6.98M | (m) | (m) |
| 2018-06-30 | $6.00K | $476.97M | $-36.00K | $-313.52M | $163.41M | 3 month · $2.60M 6 month · $5.03M | (m) | (m) |
| 2018-03-31 | $5.00K | $420.29M | $-91.00K | $-291.23M | $128.97M | 3 month · $2.42M | (m) | (m) |
| 2018-01-02 | (m) | (m) | (m) | $4.00M | (m) | (m) | (m) | (m) |
| 2018-01-01 | (m) | (m) | (m) | $4.00M | (m) | (m) | (m) | (m) |
| 2017-12-31 | $5.00K | $417.57M | $-47.00K | $-278.21M | $139.31M | 12 month · $-64.34M | (m) | (m) |
| 2017-09-30 | $5.00K | $414.97M | $-10.00K | $-288.33M | $126.64M | (m) | (m) | (m) |
| 2017-06-30 | $5.00K | $412.62M | $-40.00K | $-267.60M | $144.98M | (m) | (m) | (m) |
| 2017-03-31 | $5.00K | $409.61M | $-48.00K | $-241.88M | $167.68M | (m) | (m) | (m) |
| 2016-12-31 | $5.00K | $407.09M | $-71.00K | $-213.88M | $193.15M | 12 month · $5.32M | (m) | (m) |
| 2016-09-30 | $5.00K | $405.51M | $-25.00K | $-182.60M | $222.89M | (m) | (m) | (m) |
| 2016-06-30 | $4.00K | $294.17M | (m) | $-153.57M | $140.60M | (m) | (m) | (m) |
| 2016-03-31 | $4.00K | $292.70M | (m) | $-124.95M | $167.75M | (m) | (m) | (m) |
| 2015-12-31 | $3.00K | $210.39M | (m) | $-101.49M | $108.90M | 12 month · $2.63M | (m) | (m) |
| 2015-09-30 | $3.00K | $209.62M | (m) | $-84.49M | $125.13M | (m) | (m) | (m) |
| 2015-06-30 | $3.00K | $208.62M | (m) | $-66.36M | $142.26M | (m) | (m) | (m) |
| 2015-03-31 | $3.00K | $133.37M | (m) | $-75.37M | $58.00M | (m) | (m) | (m) |
| 2014-12-31 | $2.00K | $132.55M | (m) | $-71.87M | $60.68M | 12 month · $1.48M | (m) | (m) |
| 2014-09-30 | $2.00K | (m) | (m) | $-67.90M | $63.30M | (m) | (m) | $131.19M |
| 2014-06-30 | $2.00K | (m) | (m) | $-67.97M | $62.87M | (m) | (m) | $130.84M |
| 2013-12-31 | (m) | $5.17M | (m) | $-68.65M | $-63.48M | 12 month · $352.00K | (m) | $5.17M |
| 2012-12-31 | (m) | (m) | (m) | (m) | $-57.39M | 12 month · $473.00K | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | $-48.26M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |